Annexon Inc.
World Rank (Aug-2026)
9,234
Market Cap (Aug-2026)
1.003 Billion USD
World Rank (Jan-05-2024)
14,389
Market Cap (Jan-05-2024)
0.375 Billion USD
World Rank (Jul-30-2023)
18,916
Market Cap (Jul-30-2023)
0.170 Billion USD
World Rank (Dec-25-2022)
16,605
Market Cap (Dec-25-2022)
0.260 Billion USD
World Rank (Jan-07-2022)
16,216
Market Cap (Jan-07-2022)
0.32 Billion USD
Annual Net Income in USD
-207 Million USD
Annual Results for Period Ending
For year ending December-2025
Company Profile
Annexon Biosciences is a Clinical Stage Biopharmaceutical company discovering, developing and commercializing breakthrough therapeutics for autoimmune and neurodegenerative disease. It is having 38 employees as on September 2020. The headquarters is in USA.
Company Website